/
Company Overview At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025.
15.96% operating margin is respectable but not wide. ROIC at 15.74%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 2.1% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$15.29B
▼ -2.1% YoY
Net Income (TTM)
$1.62B
▲ +42.7% YoY
Op. Margin
17.15%
▲ +4.0pp YoY
ROIC
16.28%
▲ +6.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$1.82B
▲ +29.0% YoY
Op. Cash Flow (TTM)
$2.26B
▲ +24.2% YoY
Net Debt
$652M
Cash & Equiv.
$1.07B
3Y CAGR: +0.4%
3Y CAGR: -7.1%
Continue Research